Published by
@ShahidNShah
@ShahidNShah
March 19 to March 21, 2024
The Colonnade, 120 Huntington Avenue, Boston, Massachusetts, 02116, United States
The 3rd Cell Therapy Potency Assay Summit (Tue, 19 Mar 2024 - Thu, 21 Mar 2024) addresses the pressing challenge of developing robust potency assays within the dynamic cell therapy landscape. With recent clinical holds experienced by Mesoblast and Verve Therapeutics highlighting this need, over 120 analytical, quality control, and regulatory experts convene to collaboratively design more effective assays. This gathering aims to scientifically link mechanisms of action to potency assays, ensuring streamlined regulatory approval and reduced hold times. Industry insights from leading organizations like BMS, J and J, Atara Biotherapeutics, Fate Therapeutics, Health Canada, among others, offer valuable perspectives for developing reproducible assays, providing comprehensive understanding across different cell types and indications in autologous and allogeneic cell therapies.
Read on www.cell-therapy-potency-assay.com
Continue reading at cell-therapy-potency-assay.com
March 19 to March 21, 2024
Hilton Boston Logan Airport, One Hotel Dr, Boston, Massachusetts, 02128, United States
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Foundation, Inc. All Rights Reserved.
Built on Dec 20, 2024 at 12:59pm